Related Experiment Videos
Testing an "in-out" targeting procedure for making subtle genomic modifications in mouse embryonic stem cells
1Department of Pathology, School of Medicine, University of North Carolina, Chapel Hill 27599-7525.
Molecular and Cellular Biology
|March 1, 1991
Summary
Researchers developed an "in-out" gene targeting method to precisely modify mouse embryonic stem cell genes. This technique successfully introduced a 4-bp insertion into the HPRT gene with high accuracy, enabling genome modification.
Area of Science:
- Molecular Biology
- Genetics
- Stem Cell Biology
Background:
- The hypoxanthine phosphoribosyltransferase (HPRT) gene is crucial for purine metabolism and is a common target for gene modification studies.
- Precise genome editing in mammalian cells is essential for understanding gene function and developing therapeutic strategies.
Purpose of the Study:
- To develop and validate an "in-out" gene targeting strategy for introducing specific modifications into the mammalian genome.
- To assess the efficiency and accuracy of the "in-out" targeting procedure in mouse embryonic stem cells.
Main Methods:
- Utilized an "in-out" homologous recombination strategy to target a 4-bp insertion into the HPRT gene locus in mouse embryonic stem cells.
- Employed selection in hypoxanthine-aminopterin-thymidine (HAT) medium to isolate HPRT+ recombinants.
- Used 6-thioguanine (6-TG) selection to identify revertants with excised vector sequences and confirmed modifications via Southern blot hybridization.
Main Results:
- Successfully introduced a 4-bp insertion into the HPRT gene of mouse embryonic stem cells.
- 88% of selected revertants accurately excised the integrated vector sequences.
- 19 out of 20 accurate revertants retained the desired 4-bp insertion in the HPRT gene.
Conclusions:
- The "in-out" targeting procedure is an effective method for precise genome modification in mammalian cells.
- This strategy offers a high degree of accuracy for introducing specific genetic alterations.
- The developed scheme provides a versatile tool for advancing mammalian genome engineering.